Speaker Profile
Other, CEO & Founder, Alethios
Biography
Zeenia Framroze is a researcher and entrepreneur who founded Alethios to lower the barriers to evidence generation in human health — for both researchers and participants. Alethios is an AI-powered decentralized research platform enabling rigorous, affordable virtual studies across life sciences, biotech, longevity, and consumer health, using real-world data from wearables, sensors, and at-home biomarker kits. The Alethiad Participant Community connects researchers with thousands of engaged citizen scientists, enabling faster enrollment, high retention, and participants who are partners in the research process — not just subjects.
Her work spans digital biomarkers, decentralized clinical research, and long COVID, with peer-reviewed publications in Frontiers in Neurology and Karger Digital Biomarkers, a First Opinion piece in STAT News, and speaking engagements ranging from CNS Summit to SupplySide Global. She holds degrees from Harvard and Oxford, where she studied political theory — a foundation that shaped her belief that rigorous research should be accessible to all.
Session Abstract – PMWC 2026 Silicon Valley
Track Chair:
Michael Goldman, SFSU
PMWC Award Ceremony
• David Sinclair, Harvard
• Steve Horvath, Altos Labs
• Nir Barzilai, Albert Einstein College of Medicine
AI-Driven Biomarkers to Quantify Aging
• Chair: Alex Zhavoronkov, Insilico Medicine
• Mahdi Moqri, Harvard
• Steve Horvath, Altos Labs
• Hussain Ahamed, Ultrahuman
Epigenetic Aging Signatures in Large Human Cohorts
• Varun Dwaraka, TruDiagnostic
AI Systems for Personalized Longevity: How Biomarkers Translate into Actionable Interventions
• Chair: Nathan Price, Buck Institute
• Sherry Zhang, Buck Institute
• Ranjan Sinha, Digbi Health
• Zeenia Framroze, Alethios, Inc.
• John Ramunas, Rejuvenation Technologies
Clinical Trial Design & Functional Endpoints for Healthspan
• Nir Barzilai, Albert Einstein College of Mediciney
The data We Need For AI To Accelerate Longevity Drugs
• Martin Jensen, Gordian Biotechnology
From Genome to an AI-Drive Longevity Platform
• Wei-Wu He, Human Longevity
Wellness Wearables: The Journey to Clinical
• Hussain Ahamed, Ultrahuman
Longevity Medicine: Ambition vs Evidence in the Era of Precision Health
• Aubrey de Grey, LEV Foundation
Precision Aging & Longevity Focused on Limited Lifespan Evidence, Vanishing Blue Zones, and Payer ROI
• S. Jay Olshansky, University of Illinois
Evolutionary perspectives on human lifespan and healthspan
• Michael Gurven, UC Santa Barbara
Davos of Precision Medicine
PMWC 2027 Program
January 27–29, 2027 · Santa Clara Convention Center
Swipe speakers · Tap a card for sessions →
In a few words.
PMWC is indeed The Davos of Biotech
PMWC Hall of Impact
Previous Speakers Include
Nobel laureates, technology founders, regulators, CEOs and scientific pioneers who have taken the PMWC stage.
